Filgrastim biosimilar (Probiomed)

非格司亭生物类似药（Probiomed）

Report date: 2022/01/14 13:23:58

Base Information

Drug NameFilgrastim biosimilar (Probiomed)

Drug Alias Name重组人粒细胞刺激因子（Probiomed）rhGCSF (Probiomed)rhG-CSF (Probiomed)非格司亭生物仿制药（Probiomed）Recombinant human granulocyte-colony stimulating factor (Probiomed) +[7]

ClassificationBiologics > BiosimilarBiologics > Protein drugs > Recombinant protein > Recombinant cytokines

Mechanisms of ActionColony stimulating factor 3 receptor agonists

TargetsColony stimulating factor 3 receptor

Therapy Area/IndicationsNeutropenia

Global Approved IndicationsNeutropenia

Approved Indications in ChinaN/A

Original Approved Country/TerritoryMexico

Original Approved Date2006/03/01

Country/TerritoryMexico

CombinationsNo

Global Highest StatusApproved

Highest Status in ChinaN/A

Originator CompaniesProbiomed

China Registration ClassN/A

Develop Information

Active CompaniesProbiomed

Inactive CompaniesN/A

Active IndicationsNeutropenia

Inactive IndicationsN/A

Other Information

ATC CodeL03AA02